These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27827)

  • 21. [The characteristics of the anxiolytic action of benzodiazepine and non-benzodiazepine tranquilizers in different tests of anxiety].
    Talalaenko AN; Abramets II; Stakhovskiĭ IuV; Shekhovtsov AA; Shevchenko SL; Chernikov AV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):144-51. PubMed ID: 1349783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protein synthesis and the mechanisms of lasting change in anxiety induced by severe stress.
    Adamec R; Strasser K; Blundell J; Burton P; McKay DW
    Behav Brain Res; 2006 Feb; 167(2):270-86. PubMed ID: 16256211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Significance of autonomic arousal for the development and persistence of anxiety states (author's transl)].
    Strian F; Klicpera C
    Nervenarzt; 1978 Oct; 49(10):576-83. PubMed ID: 364325
    [No Abstract]   [Full Text] [Related]  

  • 24. The psychophysiology of anxiety.
    Lader M
    Encephale; 1983; 9(4 Suppl 2):205B-210B. PubMed ID: 6144515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The medicinal treatment of anxiety in alcoholism in the withdrawal stage (author's transl)].
    Guthy H
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1387-90. PubMed ID: 241014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Behavioral models of anxiety in animals].
    Thiebot MH
    Encephale; 1983; 9(4 Suppl 2):167B-176B. PubMed ID: 6144511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of anxiolytic drug screening tests: hormetic dose responses predominate.
    Calabrese EJ
    Crit Rev Toxicol; 2008; 38(6):489-542. PubMed ID: 18615308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical manifestations of anxiety and their treatment (author's transl)].
    Zapletálek M
    Cesk Psychiatr; 1980 Apr; 76(2):78-84. PubMed ID: 6105018
    [No Abstract]   [Full Text] [Related]  

  • 29. [Anxiety and the mechanisms of action of anxiolytics].
    Marino A; Costa R
    Recenti Prog Med; 1993 Feb; 84(2):129-41. PubMed ID: 8096650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical and therapeutic approach to anxiety-depression syndromes. Effectiveness of bromazepam (author's transl)].
    Dachary JM; Rousseau C
    Nouv Presse Med; 1982 May; 11(22):1710-2. PubMed ID: 6124939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pharmacotherapy of anxiety practice (author's transl)].
    Al-Shaltchi B; Pöldinger W
    Ther Umsch; 1975 Aug; 32(8):486-96. PubMed ID: 240216
    [No Abstract]   [Full Text] [Related]  

  • 32. Concurrent nociceptive stimulation impairs the anxiolytic effect of midazolam injected into the periaqueductal gray in mice.
    Mendes-Gomes J; Nunes-de-Souza RL
    Brain Res; 2005 Jun; 1047(1):97-104. PubMed ID: 15893297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The effect of calcium channel blockers on animal behavior in tests to study their anxiolytic activity].
    Kozlovskiĭ VL; Prakh'e IV
    Eksp Klin Farmakol; 1995; 58(1):18-20. PubMed ID: 7787686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients.
    Minervini MG; Priore P; Farolfi A; Cesana B; Morselli PL
    Pharmacopsychiatry; 1990 Mar; 23(2):102-6. PubMed ID: 1971117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease.
    Karlsson RM; Holmes A
    Amino Acids; 2006 Oct; 31(3):231-9. PubMed ID: 16733616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronobiological similarity of the specific activity of anxiolytic and antidepressant drugs].
    Arushanian EB; Beĭer EV
    Eksp Klin Farmakol; 2007; 70(5):52-8. PubMed ID: 18074809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anxiety in ambulatory and hospital practice: effects of a new anxiolytic agent, bromazepam, in a homogeneous series of 30 patients (author's transl)].
    Billé J; Dalmas C
    Nouv Presse Med; 1982 May; 11(22):1706-9. PubMed ID: 6124938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variations in illumination, closed wall transparency and/or extramaze space influence both baseline anxiety and response to diazepam in the rat elevated plus-maze.
    Violle N; Balandras F; Le Roux Y; Desor D; Schroeder H
    Behav Brain Res; 2009 Oct; 203(1):35-42. PubMed ID: 19389429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental models of anxiety for drug discovery and brain research.
    Hart PC; Bergner CL; Smolinsky AN; Dufour BD; Egan RJ; Laporte JL; Kalueff AV
    Methods Mol Biol; 2010; 602():299-321. PubMed ID: 20012406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.